3.05 pm Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014: MEDICLIN raises full-year guidance for the 2024 financial year

MEDICLIN Aktiengesellschaft (Ticker: MED) announces that it is raising its guidance for the 2024 financial year.

Instead of a Group EBIT* between EUR 33.0 and 39.0 million, MEDICLIN now expects a Group EBIT between EUR 48.0 and 54.0 million. The sales forecast for the Group was raised from -2.0 % to 0.0 % to now 1.0 % to 3.0 %.

The preliminary figures for the fourth quarter and the 2024 financial year will be published on 27 February 2025.

* As defined on the company's website at the following link.                    

Ender Gülcan

Head of Investor Relations and Sustainability

MEDICLIN Unternehmenszentrale

• Tel.:  +49 781 488 326
• Fax.: +49 781 488 184
• Write message